Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > WallStreet Research Initiates Coverage of BioSante Pharmaceuticals

March 26th, 2004

WallStreet Research Initiates Coverage of BioSante Pharmaceuticals

Abstract:
WallStreet Research led by Alan Stone, Managing Director of Alan Stone & Company, LLC, announced today that it has released an analyst research report initiating coverage of BioSante Pharmaceuticals, Inc. The complete analyst research report on BioSante Pharmaceuticals, Inc., together with the risks associated therewith and additional information about WallStreet Research is available online.

Source:
Businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Financial Reports

Nanometrics Announces Preliminary Results for the Third Quarter of 2017: Quarterly Results Impacted by Delays in Revenue Recognition on Multiple Systems into Japan October 12th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Third Quarter Results July 27th, 2017

Nanometrics to Announce Second Quarter Financial Results on August 1, 2017 July 14th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project